Gilead Sciences Ireland

Company snapshot

Gilead Sciences, Inc. ([/ˈɡɪliəd/](en.wikipedia.org/wiki/Help:IPA/English)) is an American [biopharmaceutical](en.wikipedia.org/wiki/Biopharmaceutical) company headquartered in [Foster City, California](en.wikipedia.org/wiki/Foster_City,_Calif), that focuses on researching and developing [antiviral drugs](en.wikipedia.org/wiki/Antiviral_drug) used in the treatment of [HIV/AIDS](en.wikipedia.org/wi

• 26 active pipeline program(s) linked via ClinicalTrials.gov.
• 26 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for Gilead Sciences Ireland. Not investment advice.

• Peer + 0 momentum

  Lakefront Biotherapeutics NV

  TA overlap score 49.8

• Peer + 0 momentum

  Vertex Pharmaceuticals (Australia)

  TA overlap score 40

• Peer + 0 momentum

  AbbVie

  TA overlap score 28.2

Recent activity

Latest pipeline, patent, and corporate events for Gilead Sciences Ireland.

1. Jun 8, 2026 Clinical update

   VOX — Phase 2

2. Jun 8, 2026 Clinical update

   SOF — Phase 2

3. Jun 8, 2026 Clinical update

   SOF — Phase 2

4. Jun 8, 2026 Clinical update

   Sacituzumab Govitecan-hziy — Phase 3

5. Jun 8, 2026 Clinical update

   COBI — Phase 3

View all clinical trial activity →

• What is Gilead Sciences Ireland?

  Gilead Sciences is a pharma organization headquartered in Foster City, USA. Primary therapeutic focus areas include Hepatitis C Virus Infection, Chronic Hepatitis B, HIV-1-infection, HCV Infection, Crohn's Disease. NovaPharmaNews links 26 clinical program(s), 0 drug profile(s), a

• Is Gilead Sciences Ireland publicly traded?

  Gilead Sciences Ireland appears in our database through regulatory marketing authorisation or clinical trial sponsor records; a US listed ticker is not shown for this entity.

• What drugs does Gilead Sciences Ireland develop or market?

  We link 17 drug profile(s) where Gilead Sciences Ireland is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/gilead-sciences-ireland-uc#company-drugs.

• What are the latest developments for Gilead Sciences Ireland?

  In the last 12 months our linked public records show 26 trial program update(s) and 0 US patent grant(s) tied to this profile.

• What therapeutic areas does Gilead Sciences Ireland focus on?

  Gilead Sciences Ireland focuses on Hepatitis C Virus Infection, Chronic Hepatitis B, HIV-1-infection based on our analysis of their pipeline programs and drug development activities.